Evidence map›Paper›PMID 40575301›Full record

ArticleJACS Au2025

Catalyst-Controlled Divergent Synthesis of Bicyclo[2.1.1]hexanes and Cyclobutenes: The Unique Effect of Au(I).

Run Lu, Jie Yang, Jia-Ming Jiang, Jie Wang, Wei Huang, Cheng Peng, Gu Zhan, Bo Han

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Run LuState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.
Jie YangState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.
Jia-Ming JiangState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.ORCID https://orcid.org/0009-0007-5420-4059
Jie WangState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.
Wei HuangState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.ORCID https://orcid.org/0000-0003-0832-1864
Cheng PengState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.ORCID https://orcid.org/0000-0003-3303-906X
Gu ZhanState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.ORCID https://orcid.org/0000-0002-5263-8263
Bo HanState Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, Sichuan, China.ORCID https://orcid.org/0000-0003-3200-4682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catalyst-controlled chemodivergent synthesis is a powerful strategy for exploring the chemical space. We report a Cu-(I)/Au-(I)-catalyzed chemodivergent reaction of bicyclo[1.1.0]-butane amides with azadienes, enabling access to two valuable product classes: bicyclo[2.1.1]-hexanes and cyclobutenes. Cu-(I) catalysis promotes a highly efficient formal cycloaddition to furnish bicyclo[2.1.1]-hexanes, whereas Au-(I) uniquely facilitates an addition-elimination pathway, selectively yielding cyclobutenes. Both transformations exhibit excellent chemoselectivity, high efficiency, and a broad substrate scope. The multifunctionalized products are readily scalable to gram quantities and undergo diverse downstream modifications including spirocyclization. DFT calculations provide mechanistic insight into divergent reactivity. Cu-(I) favors a linear two-coordinate geometry in the transition state, accelerating the intramolecular cyclization. In contrast, Au-(I) stabilizes key intermediates via a four-coordinate geometry, enabling intramolecular proton transfer and reversing the inherent chemoselectivity. This work highlights Au-(I)'s unique property as a useful tool for controlling reaction pathways and expanding chemical space through molecular diversification.

Indexed as

bicyclo[1.1.0]butanebicyclo[2.1.1]hexanecatalyst-controlled selectivitychemodivergent reactionscyclobutene

Identifiers

PMID40575301
PMCPMC12188400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.